Abstract
We evaluated the neuroprotective effects of β-methylphenylalanine in an experimental model of rotenone-induced Parkinson's disease (PD) in SH-SY5Y cells and rats. Cells were pre-treated with rotenone (2.5 µg/mL) for 24 hours followed by β-methylphenylalanine (1, 10 and 100 mg/L) for 72 hours. Cell viability, reactive oxygen species (ROS) levels, mitochondrial membrane potential (MMP), mitochondrial fragmentation, apoptosis, and mRNA and protein levels of tyrosine hydroxylase were determined. In a rat model of PD, dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) levels, bradykinesia and tyrosine hydroxylase expression were determined. In rotenone-pre-treated cells, β-methylphenylalanine significantly increased cell viability and MMP, whereas ROS levels, apoptosis and fragmented mitochondria were reduced. β-Methylphenylalanine significantly increased the mRNA and protein levels of tyrosine hydroxylase in SH-SY5Y cells. In the rotenone-induced rat model of PD, oral administration of β-methylphenylalanine recovered DA and DOPAC levels and bradykinesia. β-Methylphenylalanine significantly increased the protein expression of tyrosine hydroxylase in the striatum and substantia nigra of rats. In addition, in silico molecular do...Continue Reading
References
Oct 9, 2001·The Journal of Biological Chemistry·B Blanchard-FillionH Ischiropoulos
Aug 31, 2002·Nucleic Acids Research·Birgit Liss
Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
Jun 7, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Alexander D DmitrievOleg S Brusov
Feb 20, 2009·Current Opinion in Otolaryngology & Head and Neck Surgery·Alexander C Chester
Apr 30, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hyun Sook ChoiMyung Koo Lee
Jul 3, 2010·Neurobiology of Aging·Giuseppe FilomeniMaria R Ciriolo
Mar 31, 2011·Amino Acids·M Flint Beal
Jun 10, 2011·Journal of Visualized Experiments : JoVE·Dinesh C Joshi, Joanna C Bakowska
Aug 2, 2011·Biological & Pharmaceutical Bulletin·Shen Li, Xiao-Ping Pu
Feb 23, 2012·Neuromolecular Medicine·Gaetano GorgoneDaniela Caccamo
Apr 10, 2012·CNS & Neurological Disorders Drug Targets·Shams TabrezMohammad A Kamal
Sep 18, 2012·Acta Physiologica Hungarica·Gy KovácsGy Horváth
May 7, 2013·Progress in Neurobiology·Sudhakar Raja Subramaniam, Marie-Francoise Chesselet
Jan 7, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Hyo Geun KimMyung Sook Oh
Mar 4, 2014·PloS One·Mohammad S JamalMohd Rehan
Dec 3, 2014·Behavioural Brain Research·Christof von WrangelMesbah Alam
Mar 20, 2015·Cell Cycle·Alejandro Martorell-RieraFrancesc X Soriano
Oct 21, 2015·Journal of Visualized Experiments : JoVE·Andréa AllaireMartin Bisaillon
Aug 27, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nuramatjan AblatXiaoping Pu
Nov 11, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Zhen-Guo ZhuCheng-Long Xie
May 19, 2017·Amino Acids·Muthuraman PanduranganDoo Hwan Kim
Feb 9, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Rose B Creed, Matthew S Goldberg
Mar 13, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shi-Xiang RenHuan Li
May 15, 2019·Biology·Chun ChenAmy K Reeve